NDRG2 antagonizes TGFβ1-mediated tumor cell invasion by down-regulating the expression of matrix metalloproteinase 2 (MMP2) and laminin 332 pathways, with concomitant suppression of Rho GTPase activity [11]. Here, NDRG2 is linked to neoplasm.